Cooper D, Moisan J, Abdous B, Grégoire JP. A POPULATION-BASED COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE AND RISPERIDONE AMONG AMBULATORY PATIENTS WITH SCHIZOPHRENIA. J Popl Ther Clin Pharmacol. 2018;15(3). Accessed November 19, 2024. https://mail.jptcp.com/index.php/jptcp/article/view/229